Table 2.
Characteristics of the 206 EOC patients surgically treated between 2007-2008
| Stage I | Stage II | Stage III-IV | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mean age (years ± SD) |
55.6 ± 15.6 |
56.5 ±10.6 |
63.6 ± 13.0 |
||||||||||
| |
N. |
% |
N. |
% |
N. |
% |
|||||||
|
Surgical procedures |
|
|
|
|
|
|
|||||||
| Washing |
41 |
87.2 |
11 |
73.3 |
70 |
48.6 |
|||||||
| Hysterectomy |
40 |
85.1 |
15 |
100 |
96 |
66.7 |
|||||||
| Annessiectomy |
47 |
100.0 |
15 |
100 |
144 |
100 |
|||||||
| Omentectomy |
41 |
87.2 |
15 |
100.0 |
91 |
63.2 |
|||||||
| Appendectomy |
21 |
44.7 |
6 |
40.0 |
30 |
20.8 |
|||||||
| Peritoneal biopsy |
33 |
70.2 |
11 |
73.3 |
70 |
48.6 |
|||||||
| Pelvic lymphadenectomy |
20 |
42.6 |
10 |
66.7 |
49 |
34.0 |
|||||||
| Lumbo-aortic lymphadenectomy |
17 |
36.2 |
5 |
33.3 |
33 |
22.9 |
|||||||
| Peritonectomy |
3 |
6.4 |
1 |
6.7 |
25 |
17.4 |
|||||||
| Colecistectomy |
1 |
2.1 |
0 |
0.0 |
5 |
3.5 |
|||||||
| Bowel resection |
0 |
0 |
0 |
0 |
20 |
13.9 |
|||||||
| Splenectomy |
0 |
0 |
0 |
0 |
4 |
2.8 |
|||||||
|
Total |
47 |
|
15 |
|
144 |
|
|||||||
|
Residual disease |
|
|
|
|
|
|
|||||||
| Not reported |
17 |
36.2 |
8 |
53.3 |
37 |
25.7 |
|||||||
| No residual disease |
28 |
59.6 |
7 |
46.7 |
29 |
20.1 |
|||||||
| <=1 cm |
0 |
0.0 |
0 |
0.0 |
7 |
4.9 |
|||||||
| > = 2 cm |
0 |
0.0 |
0 |
0.0 |
23 |
16.0 |
|||||||
| Residual disease present but the diameter is not specified |
0 |
0.0 |
0 |
0.0 |
16 |
11.1 |
|||||||
| Missing |
2 |
4.3 |
0 |
0 |
32 |
22.2 |
|||||||
|
Total |
47 |
100 |
15 |
100 |
144 |
100 |
|||||||
|
Survival at four years from surgically treatment |
|
|
|
|
|
|
|||||||
| Live free of disease |
36 |
76.6 |
6 |
40.0 |
37 |
25.7 |
|||||||
| Dead |
0 |
0.0 |
2 |
13.3 |
44 |
30.6 |
|||||||
| Live with disease |
3 |
6.4 |
4 |
26.7 |
39 |
27.1 |
|||||||
| No data |
8 |
17.0 |
3 |
20.0 |
24 |
16.7 |
|||||||
|
Total |
47 |
100 |
15 |
100 |
144 |
100 |
|||||||
|
Type of treatment |
|
|
|
|
|
|
|||||||
| Only surgery |
24 |
46.8 |
- |
- |
8 |
5.6% |
|||||||
| Surgery plus adjuvant chemotherapy |
22 |
51.1 |
14 |
93.3 |
74 |
51.4% |
|||||||
| Neo adjuvant chemotherapy plus surgery plus chemotherapy |
1 |
2.1 |
1 |
6.7 |
35 |
24.3% |
|||||||
| Only chemotherapy |
- |
- |
- |
- |
24 |
16.7% |
|||||||
| Supportive care |
- |
- |
- |
- |
3 |
2.1% |
|||||||
| Total | 47 | 100 | 15 | 100 | 144 | 100 | |||||||